CLEC5A and infection: In contrast, administration of anti-CLEC5A mAb from day 0 (150 μg/mouse on days 0, 2, 4, 6, and 8) protected mice from early lethality (80% survival), and ∼50% mice survived for at least 16 days post infection (Figure 7A).